Table 1 Type of participants, reported outcomes and follow-up periods
Studies | Outcomes | Follow-up periods | Type of patients |
|---|---|---|---|
Blondal 2012 [9] | MACEs, MI, revascularization, death | 2.1Â years | AMI |
Buja 2012 [26] | MACEs, death, MI, TVR, TLR | 24.3Â months | CAD |
Holland 2013 [12] | Death, MACEs, revascularization | 5Â years | CAD |
Lin 2013 [27] | Death | 5.4Â years | CAD |
Michelle 2003 [25] | Death | 1Â year | CAD |
Younan 2015 [28] | Death, MI, TVR, MACEs | 1Â year | CAD |
Epps 2016 [29] | MACEs, death, MI, revascularization, TLR, TVR | In-hospital, 1 and 5Â years | CAD |
Toyota 2013 [30] | Death, MACEs, TLR, revascularization | In-hospital and 3Â years | AMI |
Cheng 2004 [31] | Death | 30Â days | AMI |
Eitel 2011 [32] | Death | 30Â days | STEMI |
Kosuge 2006 [33] | Death, MI | In-hospital | AMI |
Liu 2015 [11] | Death, MI | 30Â days | AMI |
Qi 2010 [34] | Death, MI, MACEs, TLR | 30Â days | STEMI |
Roffi 2013 [10] | Death, MI | 30Â days | STEMI |
Zanchi 2009 [35] | Death | In-hospital | STEMI |